An increasing body of evidence indicates that p53, the product of a tumour suppressor gene, has a role in development -could this developmental role have provided the primary driving force in the evolution of a protein best known as a stress-response integrator?
The incidence of most tumours progressively increases from nearly zero in childhood to a high level in old age. The rate of increase is rapid, typically being proportional to the fifth or sixth power of age. Hence most tumours affect individuals outside their reproductive prime. Until relatively recently, the age structure of human populations was quite different from the ageing populations now seen in the developed world. Indeed, the 29 year increase in life expectancy in the USA since 1900 is about the same as the increase in life expectancy seen in the 5000 years prior to 1900 [1] .
Thus the prevalence of cancer in human populations is certainly a feature of the modern epoch. Animals in the wild are subject to predation, disease and competition, and so the usual age structure is such that young animals greatly outnumber old. The observed incidence of neoplasms in wild animals will be lower than expected, as sick tumour-bearing animals will tend quickly to be eaten by predators. Despite this ascertainment bias, and while neoplasms are seen in a wide range of animals (including diverse invertebrates), they are in general rare in nonhuman animals.
The rarity of tumours in young, reproductively-competent animals requires explanation. This might be a consequence of both the time-dependent accumulation of carcinogenic exposure and also the need for multiple genetic events to occur. However, the existence of a range of genetic syndromes in which neoplasms occur in early life -such as xeroderma pigmentosa, familial adenomatous polyposis and ataxia telangiectasia -argues that a strong selective pressure exists for the evolution of systems that prevent neoplasia. The absence of genes that play a part in the prevention of neoplasia leads to increased tumour incidence -hence their classification as 'tumour suppressor' genes.
Studies of 'knockout' mice, in which specific genes have been inactivated by targeted recombination, indicate that some tumour suppressor genes, such as Retinoblastoma (Rb), are clearly essential for development, whereas others, such as those whose products are involved in the mismatch repair of damaged DNA, are not. Some of these genes clearly exert true tumour-suppressive effects, while others act by preventing the accumulation of somatic mutation, the molecular substrate for neoplasia. But may there be alternative -or complementary -explanations for the existence of such genes? In particular, is this 'suppression of neoplasia' model sufficient, or even necessary, to account for the evolution of the tumour-suppression pathway that involves the well-known p53 protein?
Having once been a curiosity of tumour virologists and a rather unusual 'oncogene', there is now no doubt that p53 acts in mammals as a potent tumour suppressor, and that abnormalities of the p53 gene that inactivate the p53 pathway are critical steps in a majority of human and rodent tumours. The currently prevalent model of p53 function is as a central integrator of stress-induced adaptive cell responses [2, 3] . Stabilization and activation of p53 protein occurs not only after genotoxic insult, but after a diverse range of other cellular stresses, such as the deregulation of microtubule assembly, detachment of cells from their normal substrate, addition or withdrawal of cytokines and growth factors, hypoxia and cell ageing. Activated p53 can then elicit, via both its sequencespecific DNA-binding properties and other poorly understood properties, a range of adaptive responses that include growth arrest and apoptosis. By these means, p53 acts as a tumour suppressor. It is generally held that this is the primary function of p53, but it is rarely considered how this could be selected for by evolution, given that the tumours in which p53 abnormalities occur are diseases of late or post-reproductive life. Recent studies suggest a more fundamental role for p53, not as a tumour suppressor, but as a teratological suppressor.
The recognition of p53 as a tumour suppressor gene in the late 1980s and speculations about its possible role in cellcycle control led to the view that p53 would turn out to be an essential element in mammalian cells. In addition, the earlier observations of developmentally regulated p53 expression [4] [5] [6] suggested that p53 may have a role in development. However, the demonstration by Donehower et al. [7] in 1992 that p53 null mice are viable quickly led to the view that p53 is entirely dispensable for normal development. Recently, more detailed analyses have shown that a substantial fraction of p53 null mice do in fact have significant developmental abnormalities, including profound neural-tube defects associated with overgrowth of neural tissue, and the affected embryos frequently undergo resorption [8, 9] . This is manifest as smaller litter size with a relative deficiency of females. Furthermore, recent observations indicate that p53 has a role in neuronal differentiation [10, 11] , and the developing nervous system is the only site in which p53 protein can be detected during mouse development [12] . In this situation, paradoxically, it is a fall in p53 levels that is associated with differentiation and concomitant cell-cycle exit. This suggests that p53 has yet-undiscovered functions over and above its role in the induction of apoptosis and growth arrest.
The over-expression of wild-type p53 protein, in transgenic mice and other systems, has been shown to be detrimental to normal development. The forced overexpression of wild-type p53 during mouse development has proved difficult, but recently Godley et al. [13] succeeded and found that there were profound alterations of renal development. Earlier studies of p53 over-expression in the lens [14] and in Xenopus oocytes [15] also showed that development was disrupted, suggesting that too much p53 protein is not compatible with normal development. Adult mammalian tissues contain very low levels of p53 protein and show considerable heterogeneity in the induction of the p53 pathway by ionizing radiation. This pattern is set up in development from a situation where all cells respond by turning on the p53 pathway and the downstream events, and there is a progressive restriction in the response during embryonic and fetal life [12] .
Lutzker and Levine [16] have recently reported that teratocarcinoma cells have high levels of transcriptionally inactive p53 protein, which diminishes on differentiation of the cells in this in vitro system (paralleling the important observations of Rogel et al. [4] and Louis et al. [5] ). Finally, the importance of p53 in development is emphasized by the dramatic rescue of early embryonic lethality in mdm2 null mice by deletion of p53 -the implication is that the MDM2 protein, known to form a complex with p53, is a critical negative regulator of p53, and the lethality of the mdm2 null mutants is due to overactivation of the p53 pathway [17, 18] . Taken together, these data suggest that the level of p53 protein expression has to be very carefully controlled in development. While normal development can occur in the absence of p53, there is a significant risk of embryonic or fetal loss [8, 9] , and, in addition, too much p53 can be harmful during normal developmental processes [13] [14] [15] . What, then, is the role of p53 during development?
Two important papers [19, 20] indicate that p53 can act as a teratological suppressor, in that the presence of a functional p53 pathway reduces the amount of defective embryos/foetuses after exposure to drugs or radiation: in the absence of functional p53, there is a big increase in 'embryopathy'. Nicol et al. [19] found that there was a 2-4-fold increase in the embryotoxicity and teratogenicity of the environmental teratogen benzo[a]pyrene in p53 null animals compared with wild-type controls. They went on to show that there was 3.6-fold increase in the fetal resorption of homozygous p53 -/-mice, with heterozygous p53 +/-mice having an intermediate level of resorption.
Norimura et al. [20] reported similar observations in mice exposed to X-irradiation in utero. In p53 null mice irradiated with 2 Gy of X rays, there was a 70% incidence of anomalies and 7% incidence of deaths. In contrast, in wildtype mice there was the reverse relationship of abnormalities and death -20% versus 60%. Again, the heterozygous mice had an intermediate phenotype, indicating a gene-dosage effect similar to that observed previously for p53-mediated apoptosis. These observations suggest that p53 has a critical role in mammalian development -the sensing and elimination, probably by apoptosis, of damaged cells. The role for p53-dependent apoptosis as a regulator in development is further substantiated by the observations of Wubah et al. [21] on teratogen-induced eye defects. Animals are, of course, naturally exposed to a wide range of potential teratogens -this is emphasized by the well-known very high rate of spontaneous abortion in the outbred human population [1] .
Taken together, these observations and ideas give a radically new perspective on the role and evolution of p53. It is now clear that p53 has as its primary function the coordination of multicellular adaptive responses to diverse environmental stresses [2, 3] . During development, the effective response to such stresses is of critical importance in determining successful reproductive strategies. p53 has a critical role in development, with its function manifest as a teratological suppressor [19, 20] , and we speculate that this may indeed have been the primary drive in its evolution, with the role in neoplasia being a secondary -very important, but still secondary -property.
To test such an idea will require the study of more diverse representatives of phylogeny than mice and humans. The important idea, however, is that the development of embryos in higher metazoa is regulative and requires considerable plasticity, which the adaptive p53 response can help provide. The emergence of p53 as an adaptiveresponse regulator may have been a key permissive step in the evolution of developmental complexity, facilitating the remarkable cellular plasticity seen in higher metazoa and in vertebrates in particular. It makes good biological sense for there to be a mechanism allowing vertebrates to delete 'defective' cells, so that other, normal cell populations can 'fill' the gaps. The use of p53 as a tumour suppressor would be a useful additional attribute, particularly in those complex vertebrates with complex arrangements of renewing cell hierarchies which are exposed to environmental stresses.
What is known about the evolution of p53? Soussi and May [22] have recently reviewed this topic and emphasized the important conservation in a range of vertebrates, including mammals, birds, amphibians and fish, of certain regions of p53 -in particular, the transcriptional activation domain and regions of the sequence-specific DNAbinding domain. The sequences between these regions show considerable divergence. Recently, some sequences from clam and squid have been reported that show similarities to conserved regions of vertebrate p53. Although these sequences are related to vertebrate p53, there can be no certainty regarding the biological function(s) of these putative p53 homologues.
No p53 homologues are apparent in the genome of the budding yeast Saccharomyces cerevisiae, and none has yet been reported in the fruitfly Drosophila or the nematode Caenorhabditis elegans. More work needs to be done on this, but the currently available data raise the possibility that p53 appeared relatively late in evolution, and the exact phylogenetic origin of p53 is a critical question. Raff [23] has defined a number of key regulatory events and related them to metazoan phylogeny (Fig. 1) . It may be that the emergence of tissues the development of which necessarily involves competition between cellular populations required the existence of a control gene such as p53 early in phylogeny. Alternatively, p53 may have appeared later to provide a better response to adverse external stimuli. Identifying when p53 functions emerged in phylogeny should help resolve these issues.
In conclusion, we speculate that p53 has a primary role as the 'guardian of the babies', coordinating the adaptive responses to cellular stress of many forms and acting primarily as a teratological suppressor, with a secondary role in neoplasia. This is clearly a heterodox view, but one that should stimulate debate and provide a new perspective for further research, particularly in defining the functional significance of the p53 pathway in phylogeny. Was the emergence of p53 a critical step in the development of metazoa? This would link development, evolution, stress responses and neoplasia in a unique way. A number of critical innovations underpin the evolution of metazoa [23] . The p53 gene has been well defined only in higher chordates, though it may exist in molluscs [22] . A critical issue for the future will be to define how the diverse adaptive responses mediated through the p53 pathway have evolved; this should cast light on the speculation that p53 has manifestly contributed to the evolution of development. (Adapted from [23] 
